Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vink

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
JCO Oncology Practice|April 17, 2025
Reply to: Putting IDEA's Results Into Practice: Practicality Should Rule Complexity in Stage III Colon CancerIngrid A Franken, Frederieke H van der Baan, Jeanine M L Roodhart, et al.
International Journal of Cancer|August 20, 2019
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world dataGabrielle Jongeneel, Thomas Klausch, Felice N van Erning, et al.
Journal of Geriatric Oncology|September 4, 2019
Development of a self-reported version of the G8 screening toolInez Charlotte van Walree, Ariel M Vondeling, Geraldine R Vink, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world treatment patterns and survival in patients with synchronous and metachronous metastatic colorectal cancer in the NetherlandsM A G Elferink, F N van Erning, F C Sijtsma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 18, 2006
Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumoursStefan R Vink, Jan H M Schellens, Jos H Beijnen, et al.
Journal of Clinical Pathology|October 22, 2021
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practiceElisabeth M P Steeghs, Geraldine R Vink, Marloes A G Elferink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 20, 2021
Survival of surgical and non-surgical older patients with non-metastatic colorectal cancer: A population-based study in the NetherlandsEllen van der Vlies, Lisette M Vernooij, Felice N van Erning, et al.
Clinical Colorectal Cancer|April 27, 2022
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)Patricia A H Hamers, Geraldine R Vink, Marloes A G Elferink, et al.
International Journal of Cancer|January 18, 2021
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort studyGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
British Journal of Cancer|May 20, 2024
Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximabKoen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
JCO Oncology Practice|April 17, 2025
Reply to: Putting IDEA's Results Into Practice: Practicality Should Rule Complexity in Stage III Colon CancerIngrid A Franken, Frederieke H van der Baan, Jeanine M L Roodhart, et al.
International Journal of Cancer|August 20, 2019
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world dataGabrielle Jongeneel, Thomas Klausch, Felice N van Erning, et al.
Journal of Geriatric Oncology|September 4, 2019
Development of a self-reported version of the G8 screening toolInez Charlotte van Walree, Ariel M Vondeling, Geraldine R Vink, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world treatment patterns and survival in patients with synchronous and metachronous metastatic colorectal cancer in the NetherlandsM A G Elferink, F N van Erning, F C Sijtsma, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 18, 2006
Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumoursStefan R Vink, Jan H M Schellens, Jos H Beijnen, et al.
Journal of Clinical Pathology|October 22, 2021
Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practiceElisabeth M P Steeghs, Geraldine R Vink, Marloes A G Elferink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 20, 2021
Survival of surgical and non-surgical older patients with non-metastatic colorectal cancer: A population-based study in the NetherlandsEllen van der Vlies, Lisette M Vernooij, Felice N van Erning, et al.
Clinical Colorectal Cancer|April 27, 2022
Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)Patricia A H Hamers, Geraldine R Vink, Marloes A G Elferink, et al.
International Journal of Cancer|January 18, 2021
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort studyGabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning, et al.
British Journal of Cancer|May 20, 2024
Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximabKoen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, et al.
Pageof 21